Published : Apr-2019
No. of Pages : 45
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Artificial Lung Overview
3 Products under Development
3.1 Artificial Lung - Pipeline Products by Stage of Development
3.2 Artificial Lung - Pipeline Products by Territory
3.3 Artificial Lung - Pipeline Products by Regulatory Path
3.4 Artificial Lung - Pipeline Products by Estimated Approval Date
3.5 Artificial Lung - Ongoing Clinical Trials
4 Artificial Lung - Pipeline Products under Development by Companies
4.1 Artificial Lung Companies - Pipeline Products by Stage of Development
4.2 Artificial Lung - Pipeline Products by Stage of Development
5 Artificial Lung Companies and Product Overview
5.1 ALung Technologies Inc Company Overview
5.2 Breethe, Inc. Company Overview
5.3 Case Western Reserve University Company Overview
5.4 Haemair Ltd Company Overview
5.5 Lung Biotechnology PBC Company Overview
5.6 MC3 Inc Company Overview
5.7 McGowan Institute for Regenerative Medicine Company Overview
5.8 MedArray Inc. Company Overview
5.9 Miromatrix Medical Inc Company Overview
5.10 University of California San Francisco Company Overview
5.11 University of Michigan Company Overview
5.12 University of Pittsburgh Company Overview
5.13 Xenios AG Company Overview
6 Artificial Lung- Recent Developments
6.1 Jan 24, 2019: Temple joins pivotal clinical trial testing minimally invasive approach to carbon dioxide removal for patients experiencing acute COPD exacerbations
6.2 Dec 10, 2018: ALung announces significant progress in its Hemolung clinical trial programs
6.3 Sep 24, 2018: VA researchers work to create 3D-printed artificial lung that may revolutionize treatment of Veterans with lung disease
6.4 Sep 04, 2018: Pivotal trial of ALung's artificial lung technology reaches record enrollment
6.5 Aug 01, 2018: UTMB researchers successfully transplant bioengineered lung
6.6 Jul 26, 2018: Ren breathes life into damaged lungs
6.7 Jun 19, 2018: ChemE Graduate Student Alexandra May Receives Willem Kolff Award At ASAI Annual Meeting
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Artificial Lung - Pipeline Products by Stage of Development
Table 2: Artificial Lung - Pipeline Products by Territory
Table 3: Artificial Lung - Pipeline Products by Regulatory Path
Table 4: Artificial Lung - Pipeline Products by Estimated Approval Date
Table 5: Artificial Lung - Ongoing Clinical Trials
Table 6: Artificial Lung Companies - Pipeline Products by Stage of Development
Table 7: Artificial Lung - Pipeline Products by Stage of Development
Table 8: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Hemolung RAS - Product Status
Table 10: Hemolung RAS - Product Description
Table 11: ALung Technologies Inc - Ongoing Clinical Trials Overview
Table 12: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Table 13: Hemolung RAS - Enhanced Lung Protective Ventilation with Extracorporeal CO2 Removal During Acute Respiratory Distress Syndrome
Table 14: Hemolung RAS - Evaluation of Clinical Effectiveness of ECCO2R for the Treatment of Patients with Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Table 15: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD
Table 16: Hemolung RAS - HL-CA-1600, Hemolung RAS Registry. A Retrospective Registry Involving Voluntary Reporting of De-identified, Standard of Care Data Following the Commercial Use of the Hemolung Respiratory Assist System (RAS)
Table 17: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure
Table 18: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: OXY-1 - Product Status
Table 20: OXY-1 - Product Description
Table 21: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Portable Artificial Lung - Product Status
Table 23: Portable Artificial Lung - Product Description
Table 24: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Extracorporeal Membrane Oxygenation (ECMO) Device - Product Status
Table 26: Extracorporeal Membrane Oxygenation (ECMO) Device - Product Description
Table 27: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
Table 28: 3D Bioprinted Lung Transplant - Product Status
Table 29: 3D Bioprinted Lung Transplant - Product Description
Table 30: Implantable Artificial Lung - Product Status
Table 31: Implantable Artificial Lung - Product Description
Table 32: MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: BioLung - Product Status
Table 34: BioLung - Product Description
Table 35: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Biohybrid Artificial Lung - Product Status
Table 37: Biohybrid Artificial Lung - Product Description
Table 38: Chronic Artificial Lung - Product Status
Table 39: Chronic Artificial Lung - Product Description
Table 40: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Artificial Lung Fiber - Product Status
Table 42: Artificial Lung Fiber - Product Description
Table 43: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Miromatrix Artificial Lung - Product Status
Table 45: Miromatrix Artificial Lung - Product Description
Table 46: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
Table 47: ECMO Device - Product Status
Table 48: ECMO Device - Product Description
Table 49: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
Table 50: M-Lung - Product Status
Table 51: M-Lung - Product Description
Table 52: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
Table 53: P-PAL - Product Status
Table 54: P-PAL - Product Description
Table 55: Paracorporeal Ambulatory Assist Lung - Product Status
Table 56: Paracorporeal Ambulatory Assist Lung - Product Description
Table 57: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview
Table 58: i-lung - Product Status
Table 59: i-lung - Product Description
Table 60: Xtralung - Product Status
Table 61: Xtralung - Product Description
Table 62: Glossary
1.2 List of Figures
Figure 1: Artificial Lung - Pipeline Products by Stage of Development
Figure 2: Artificial Lung - Pipeline Products by Territory
Figure 3: Artificial Lung - Pipeline Products by Regulatory Path
Figure 4: Artificial Lung - Pipeline Products by Estimated Approval Date
Figure 5: Artificial Lung - Ongoing Clinical Trials
